<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>CyberShield Rural — Capital Thesis</title>
  <style>
/* ====================================================================
   DESIGN SYSTEM — Venture Forge
   ==================================================================== */
:root {
  --bg-primary: #09090b;
  --bg-secondary: #18181b;
  --bg-card: #1f1f23;
  --bg-card-hover: #27272a;
  --accent: #8b5cf6;
  --accent-light: #a78bfa;
  --accent-glow: rgba(139, 92, 246, 0.12);
  --text-primary: #fafafa;
  --text-secondary: #a1a1aa;
  --text-muted: #71717a;
  --border: rgba(255, 255, 255, 0.08);
  --border-accent: rgba(139, 92, 246, 0.3);
  --gradient-1: linear-gradient(135deg, #8b5cf6 0%, #06b6d4 100%);
  --green: #22c55e;
  --green-bg: rgba(34, 197, 94, 0.1);
  --green-border: rgba(34, 197, 94, 0.3);
  --amber: #fbbf24;
  --amber-bg: rgba(251, 191, 36, 0.1);
  --amber-border: rgba(251, 191, 36, 0.3);
  --red: #ef4444;
  --red-bg: rgba(239, 68, 68, 0.1);
  --red-border: rgba(239, 68, 68, 0.3);
  --cyan: #06b6d4;
}

* { margin: 0; padding: 0; box-sizing: border-box; }
html { scroll-behavior: smooth; }

body {
  font-family: 'Inter', -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  background: var(--bg-primary);
  color: var(--text-primary);
  line-height: 1.6;
  -webkit-font-smoothing: antialiased;
}

/* NAVIGATION */
nav {
  position: fixed;
  top: 0; left: 0; right: 0;
  z-index: 100;
  background: rgba(9, 9, 11, 0.8);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border-bottom: 1px solid var(--border);
  padding: 1rem 2rem;
  display: flex;
  align-items: center;
  justify-content: space-between;
}
.nav-logo {
  font-weight: 700;
  font-size: 0.95rem;
  color: var(--text-primary);
  text-decoration: none;
  letter-spacing: -0.01em;
}
.nav-links { display: flex; gap: 1.5rem; list-style: none; }
.nav-links a {
  color: var(--text-muted);
  text-decoration: none;
  font-size: 0.85rem;
  font-weight: 500;
  transition: color 0.2s;
}
.nav-links a:hover { color: var(--text-primary); }

/* LAYOUT */
.container { max-width: 1100px; margin: 0 auto; }
section { padding: 6rem 2rem; }
.section-alt { background: var(--bg-secondary); }
.section-num {
  font-size: 0.75rem;
  text-transform: uppercase;
  letter-spacing: 0.15em;
  color: var(--accent);
  font-weight: 600;
  margin-bottom: 0.75rem;
}
h2 {
  font-size: clamp(2rem, 4vw, 2.75rem);
  font-weight: 700;
  letter-spacing: -0.02em;
  margin-bottom: 1rem;
  line-height: 1.15;
}
h3 {
  font-size: 1.25rem;
  font-weight: 600;
  margin-bottom: 0.75rem;
}
.section-lead {
  font-size: 1.125rem;
  color: var(--text-secondary);
  max-width: 640px;
  margin-bottom: 3rem;
  line-height: 1.7;
}
.gradient-text {
  background: var(--gradient-1);
  -webkit-background-clip: text;
  -webkit-text-fill-color: transparent;
  background-clip: text;
}

/* NARRATIVE */
.narrative {
  padding: 4rem 2rem 6rem;
  background: var(--bg-secondary);
}
.narrative .container { max-width: 720px; }
.narrative-chapter { margin-bottom: 3rem; }
.narrative-chapter:last-child { margin-bottom: 0; }
.narrative-num {
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 0.2em;
  color: var(--accent);
  font-weight: 700;
  margin-bottom: 0.5rem;
}
.narrative-chapter h3 {
  font-size: 1.5rem;
  font-weight: 700;
  margin-bottom: 0.75rem;
  letter-spacing: -0.01em;
}
.narrative-chapter p {
  font-size: 1.05rem;
  color: var(--text-secondary);
  line-height: 1.8;
}
.narrative-chapter p strong {
  color: var(--text-primary);
  font-weight: 600;
}
.narrative-divider {
  width: 48px;
  height: 2px;
  background: var(--accent);
  opacity: 0.4;
  margin: 3.5rem 0;
}
.narrative-chapter a {
  color: var(--text-secondary);
  text-decoration: underline;
  text-decoration-color: var(--accent);
  text-underline-offset: 3px;
  text-decoration-thickness: 1.5px;
  transition: color 0.2s;
}
.narrative-chapter a:hover { color: var(--accent-light); }
.narrative-chapter a strong { color: inherit; }
.narrative-cta {
  margin-top: 3rem;
  padding: 1.5rem 2rem;
  background: var(--accent-glow);
  border: 1px solid var(--border-accent);
  border-radius: 12px;
  font-size: 1rem;
  color: var(--text-secondary);
  line-height: 1.7;
}
.narrative-cta strong { color: var(--accent-light); }

/* HERO */
.hero {
  padding: 10rem 2rem 6rem;
  text-align: center;
}
.hero h1 {
  font-size: clamp(3rem, 7vw, 4.5rem);
  font-weight: 800;
  letter-spacing: -0.03em;
  line-height: 1.05;
  margin-bottom: 1.5rem;
}
.hero .lead {
  font-size: 1.25rem;
  color: var(--text-secondary);
  max-width: 620px;
  margin: 0 auto 3rem;
  line-height: 1.7;
}
.funnel {
  display: flex;
  align-items: center;
  justify-content: center;
  gap: 0.5rem;
  flex-wrap: wrap;
  margin-bottom: 3rem;
}
.funnel-box {
  padding: 0.6rem 1.2rem;
  border: 1px solid var(--border);
  border-radius: 8px;
  font-size: 0.8rem;
  font-weight: 500;
  color: var(--text-secondary);
  background: var(--bg-card);
}
.funnel-box.highlight {
  border-color: var(--border-accent);
  background: var(--accent-glow);
  color: var(--accent-light);
}
.funnel-arrow { color: var(--text-muted); font-size: 1rem; }
.hero-stats {
  display: flex;
  justify-content: center;
  gap: 3rem;
  flex-wrap: wrap;
}
.hero-stat-value {
  font-size: 2rem;
  font-weight: 800;
  letter-spacing: -0.02em;
}
.hero-stat-value.accent { color: var(--accent-light); }
.hero-stat-value.green { color: var(--green); }
.hero-stat-label {
  font-size: 0.75rem;
  color: var(--text-muted);
  text-transform: uppercase;
  letter-spacing: 0.1em;
  margin-top: 0.25rem;
}

/* CARDS */
.card-grid { display: grid; gap: 1.5rem; }
.card-grid.cols-3 { grid-template-columns: repeat(3, 1fr); }
.card-grid.cols-2 { grid-template-columns: repeat(2, 1fr); }
.card {
  background: var(--bg-card);
  border: 1px solid var(--border);
  border-radius: 12px;
  padding: 2rem;
}
.card-label {
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 0.12em;
  font-weight: 600;
  margin-bottom: 0.75rem;
}
.card-label.purple { color: var(--accent-light); }
.card-label.green { color: var(--green); }
.card-label.amber { color: var(--amber); }
.card-label.red { color: var(--red); }
.card-label.cyan { color: var(--cyan); }
.card h3 { margin-bottom: 0.5rem; }
.card p { color: var(--text-secondary); font-size: 0.95rem; line-height: 1.65; }
.callout {
  border: 1px dashed var(--amber-border);
  background: var(--amber-bg);
  border-radius: 10px;
  padding: 1.25rem 1.5rem;
  margin-top: 2rem;
  font-size: 0.9rem;
  color: var(--text-secondary);
  line-height: 1.65;
}
.callout strong { color: var(--amber); }

/* STAT CARDS */
.stat-row {
  display: flex;
  gap: 1.5rem;
  flex-wrap: wrap;
  margin-bottom: 3rem;
}
.stat-card {
  flex: 1;
  min-width: 200px;
  background: var(--bg-card);
  border: 1px solid var(--border);
  border-radius: 12px;
  padding: 1.5rem;
  text-align: center;
}
.stat-card-value {
  font-size: 1.75rem;
  font-weight: 800;
  letter-spacing: -0.02em;
  margin-bottom: 0.25rem;
}
.stat-card-label { font-size: 0.8rem; color: var(--text-muted); }

/* DATA TABLES */
.table-wrap { overflow-x: auto; }
.data-table { width: 100%; border-collapse: collapse; font-size: 0.875rem; }
.data-table thead th {
  text-align: left;
  padding: 0.75rem 1rem;
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 0.1em;
  color: var(--text-muted);
  border-bottom: 1px solid var(--border);
  font-weight: 600;
  white-space: nowrap;
}
.data-table tbody td {
  padding: 0.75rem 1rem;
  border-bottom: 1px solid var(--border);
  color: var(--text-secondary);
  vertical-align: top;
}
.data-table tbody tr:hover { background: var(--bg-card); }
.data-table .funder-name {
  color: var(--text-primary);
  font-weight: 600;
  white-space: nowrap;
}

/* BADGES */
.badge {
  display: inline-block;
  font-size: 0.65rem;
  font-weight: 600;
  text-transform: uppercase;
  letter-spacing: 0.08em;
  padding: 0.2rem 0.55rem;
  border-radius: 4px;
}
.badge.strong { background: var(--green-bg); color: var(--green); border: 1px solid var(--green-border); }
.badge.moderate { background: var(--amber-bg); color: var(--amber); border: 1px solid var(--amber-border); }
.badge.weak { background: rgba(113,113,122,0.15); color: var(--text-muted); border: 1px solid rgba(113,113,122,0.3); }
.badge.ready { background: var(--green-bg); color: var(--green); border: 1px solid var(--green-border); }
.badge.not-ready { background: var(--amber-bg); color: var(--amber); border: 1px solid var(--amber-border); }
.badge.suspended { background: var(--red-bg); color: var(--red); border: 1px solid var(--red-border); }
.badge.na { background: rgba(113,113,122,0.1); color: var(--text-muted); border: 1px solid rgba(113,113,122,0.2); }
.badge.type-grant { background: rgba(6,182,212,0.1); color: var(--cyan); border: 1px solid rgba(6,182,212,0.3); }
.badge.type-equity { background: var(--accent-glow); color: var(--accent-light); border: 1px solid var(--border-accent); }
.badge.type-accel { background: var(--green-bg); color: var(--green); border: 1px solid var(--green-border); }
.badge.type-support { background: rgba(113,113,122,0.1); color: var(--text-muted); border: 1px solid rgba(113,113,122,0.2); }
.badge.blocking { background: var(--red-bg); color: var(--red); border: 1px solid var(--red-border); }
.badge.significant { background: var(--amber-bg); color: var(--amber); border: 1px solid var(--amber-border); }
.badge.minor { background: rgba(113,113,122,0.1); color: var(--text-muted); border: 1px solid rgba(113,113,122,0.2); }

/* ACCORDION */
.accordion { display: flex; flex-direction: column; gap: 1rem; }
.accordion-item {
  border: 1px solid var(--border);
  border-radius: 12px;
  overflow: hidden;
  background: var(--bg-card);
}
.accordion-header {
  display: flex;
  align-items: center;
  justify-content: space-between;
  padding: 1.25rem 1.5rem;
  cursor: pointer;
  transition: background 0.2s;
}
.accordion-header:hover { background: var(--bg-card-hover); }
.accordion-header-left { display: flex; align-items: center; gap: 1rem; flex-wrap: wrap; }
.accordion-header h3 { margin: 0; font-size: 1.05rem; }
.accordion-arrow {
  font-size: 1.2rem;
  color: var(--text-muted);
  transition: transform 0.3s;
  flex-shrink: 0;
}
.accordion-item.open .accordion-arrow { transform: rotate(180deg); }
.accordion-content { max-height: 0; overflow: hidden; transition: max-height 0.4s ease; }
.accordion-item.open .accordion-content { max-height: 3000px; }
.accordion-body { padding: 0 1.5rem 1.5rem; border-top: 1px solid var(--border); }
.accordion-body p { color: var(--text-secondary); font-size: 0.9rem; line-height: 1.65; margin-top: 1.25rem; }
.accordion-body h4 {
  font-size: 0.8rem;
  text-transform: uppercase;
  letter-spacing: 0.1em;
  color: var(--text-muted);
  margin-top: 1.5rem;
  margin-bottom: 0.75rem;
}

/* ALIGNMENT LISTS (inside accordions) */
.alignment-list { list-style: none; display: flex; flex-direction: column; gap: 0.5rem; }
.alignment-list li {
  font-size: 0.875rem;
  padding: 0.5rem 0.75rem;
  border-radius: 6px;
  border-left: 3px solid;
  line-height: 1.5;
}
.alignment-list li.strength { border-color: var(--green); background: var(--green-bg); color: var(--text-secondary); }
.alignment-list li.gap-item { border-color: var(--amber); background: var(--amber-bg); color: var(--text-secondary); }
.alignment-list li.gap-item.blocker { border-color: var(--red); background: var(--red-bg); }
.criteria-list { list-style: none; display: flex; flex-direction: column; gap: 0.4rem; }
.criteria-list li {
  font-size: 0.875rem;
  color: var(--text-secondary);
  padding-left: 1rem;
  position: relative;
  line-height: 1.5;
}
.criteria-list li::before { content: "\2192"; position: absolute; left: 0; color: var(--accent-light); }
.criteria-source { font-size: 0.75rem; color: var(--text-muted); font-style: italic; }

/* INLINE SOURCE LINKS */
.source-link {
  color: var(--accent-light);
  text-decoration: none;
  border-bottom: 1px dotted var(--accent-light);
  transition: color 0.2s, border-color 0.2s;
}
.source-link:hover {
  color: var(--text-primary);
  border-color: var(--text-primary);
}

/* GATE REVIEW */
.validation-card {
  background: var(--bg-card);
  border: 1px solid var(--green-border);
  border-radius: 12px;
  padding: 1.5rem 2rem;
  margin-bottom: 2.5rem;
  display: flex;
  align-items: center;
  justify-content: space-between;
  gap: 2rem;
  flex-wrap: wrap;
}
.validation-card.needs-revision {
  border-color: var(--amber-border);
}
.validation-status { display: flex; align-items: center; gap: 1rem; }
.validation-icon {
  width: 48px; height: 48px;
  border-radius: 50%;
  background: var(--green-bg);
  border: 2px solid var(--green);
  display: flex;
  align-items: center;
  justify-content: center;
  font-size: 1.5rem;
}
.validation-icon.amber-icon {
  background: var(--amber-bg);
  border-color: var(--amber);
}
.validation-text h3 { margin-bottom: 0.15rem; font-size: 1rem; }
.validation-text p { font-size: 0.85rem; color: var(--text-muted); margin: 0; }
.validation-stats { display: flex; gap: 1.5rem; }
.validation-stat { text-align: center; }
.validation-stat-value { font-size: 1.5rem; font-weight: 800; }
.validation-stat-label { font-size: 0.65rem; color: var(--text-muted); text-transform: uppercase; letter-spacing: 0.1em; }
.gate-cards { display: flex; flex-direction: column; gap: 1.25rem; }
.gate-card {
  background: var(--bg-card);
  border: 1px solid var(--amber-border);
  border-left: 4px solid var(--amber);
  border-radius: 12px;
  padding: 1.5rem 2rem;
}
.gate-card-header { display: flex; align-items: center; gap: 1rem; margin-bottom: 0.75rem; }
.gate-num {
  width: 2rem; height: 2rem;
  background: var(--amber-bg);
  border: 1px solid var(--amber-border);
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-size: 0.8rem;
  font-weight: 700;
  color: var(--amber);
  flex-shrink: 0;
}
.gate-question { font-size: 1.05rem; font-weight: 600; }
.gate-context { font-size: 0.875rem; color: var(--text-secondary); line-height: 1.6; margin-bottom: 1rem; }
.gate-options { display: flex; flex-direction: column; gap: 0.5rem; }
.gate-option {
  padding: 0.6rem 1rem;
  border: 1px solid var(--border);
  border-radius: 6px;
  font-size: 0.85rem;
  color: var(--text-secondary);
  background: var(--bg-secondary);
  line-height: 1.5;
}
.gate-option strong { color: var(--text-primary); }
.gate-consequence { color: var(--text-muted); font-size: 0.8rem; }
.gate-group-label { font-size: 1.1rem; font-weight: 600; margin-top: 2rem; margin-bottom: 0.25rem; }
.gate-group-desc { font-size: 0.85rem; color: var(--text-muted); margin-bottom: 1rem; }
.gate-card.strategic {
  border-color: var(--border);
  border-left-color: var(--text-muted);
}
.gate-card.strategic .gate-num {
  background: var(--bg-secondary);
  border-color: var(--border);
  color: var(--text-muted);
}
.gate-priority {
  font-size: 0.7rem;
  font-weight: 600;
  text-transform: uppercase;
  letter-spacing: 0.08em;
  padding: 0.15rem 0.5rem;
  border-radius: 4px;
  margin-left: auto;
}
.gate-priority.blocking { background: var(--amber-bg); color: var(--amber); border: 1px solid var(--amber-border); }
.gate-priority.strategic { background: var(--bg-secondary); color: var(--text-muted); border: 1px solid var(--border); }
.gate-revisit {
  font-size: 0.8rem;
  color: var(--accent-light);
  font-style: italic;
  margin-bottom: 1rem;
}

/* EVIDENCE BRIEFING */
.evidence-briefing {
  background: var(--bg-card);
  border: 1px solid var(--border);
  border-radius: 12px;
  padding: 2rem;
  margin-bottom: 2rem;
}
.evidence-briefing h3 {
  font-size: 1.25rem;
  margin-bottom: 1.5rem;
  color: var(--text-primary);
}
.evidence-briefing h4 {
  font-size: 0.9rem;
  text-transform: uppercase;
  letter-spacing: 0.05em;
  margin-bottom: 0.75rem;
  color: var(--text-muted);
}
.briefing-stats {
  display: flex;
  flex-wrap: wrap;
  gap: 1.5rem;
  margin-bottom: 2rem;
  padding-bottom: 1.5rem;
  border-bottom: 1px solid var(--border);
}
.briefing-stat { text-align: center; }
.briefing-stat-value {
  font-size: 1.5rem;
  font-weight: 700;
  color: var(--accent-light);
  display: block;
}
.briefing-stat-label {
  font-size: 0.75rem;
  color: var(--text-muted);
  margin-top: 0.25rem;
}
.briefing-columns {
  display: grid;
  grid-template-columns: 1fr 1fr;
  gap: 2rem;
}
.briefing-list { list-style: none; padding: 0; margin: 0; }
.briefing-list li {
  padding: 0.5rem 0 0.5rem 1rem;
  font-size: 0.875rem;
  color: var(--text-secondary);
  line-height: 1.5;
  border-left: 3px solid transparent;
}
.briefing-list.strong li { border-left-color: var(--green); }
.briefing-list.weak li { border-left-color: var(--amber); }
h4.briefing-strong { color: var(--green); }
h4.briefing-weak { color: var(--amber); }

@media (max-width: 768px) {
  .briefing-columns { grid-template-columns: 1fr; }
}

/* BAR CHART (CSS-only) */
.bar-chart { margin-top: 2rem; }
.bar-row { display: flex; align-items: center; gap: 1rem; margin-bottom: 0.75rem; }
.bar-label { width: 120px; font-size: 0.75rem; color: var(--text-muted); text-align: right; flex-shrink: 0; }
.bar-track { flex: 1; height: 24px; background: var(--bg-secondary); border-radius: 4px; overflow: hidden; }
.bar-fill {
  height: 100%;
  border-radius: 4px;
  background: var(--gradient-1);
  display: flex;
  align-items: center;
  padding-left: 0.5rem;
  font-size: 0.7rem;
  font-weight: 600;
  color: white;
  min-width: fit-content;
}

/* EVIDENCE STATS */
.evidence-stats { display: flex; gap: 1rem; flex-wrap: wrap; margin-bottom: 2rem; }
.evidence-stat {
  flex: 1;
  min-width: 120px;
  text-align: center;
  padding: 1.25rem;
  background: var(--bg-card);
  border: 1px solid var(--border);
  border-radius: 10px;
}
.evidence-stat-value { font-size: 1.75rem; font-weight: 800; color: var(--accent-light); }
.evidence-stat-label {
  font-size: 0.7rem;
  color: var(--text-muted);
  text-transform: uppercase;
  letter-spacing: 0.08em;
  margin-top: 0.25rem;
}

/* CHECKLIST */
.checklist { list-style: none; display: flex; flex-direction: column; gap: 0.5rem; }
.checklist li {
  font-size: 0.9rem;
  color: var(--text-secondary);
  display: flex;
  align-items: center;
  gap: 0.5rem;
}
.check-icon { color: var(--green); font-size: 1rem; }

/* SCALE NOTE */
.scale-note {
  background: var(--accent-glow);
  border: 1px solid var(--border-accent);
  border-radius: 10px;
  padding: 1rem 1.25rem;
  font-size: 0.875rem;
  color: var(--text-secondary);
  margin-top: 2rem;
  line-height: 1.6;
}
.scale-note strong { color: var(--accent-light); }

/* SOURCES */
.sources-grid { display: grid; gap: 2rem; margin-top: 2rem; }
.source-category { margin-bottom: 1rem; }
.source-category h3 {
  font-size: 1rem;
  font-weight: 600;
  color: var(--accent-light);
  margin-bottom: 1rem;
  text-transform: uppercase;
  letter-spacing: 0.1em;
}
.source-list { list-style: none; display: flex; flex-direction: column; gap: 0.5rem; }
.source-list li {
  font-size: 0.85rem;
  color: var(--text-secondary);
  line-height: 1.5;
  padding: 0.5rem 0;
  border-bottom: 1px solid var(--border);
}
.source-list li:last-child { border-bottom: none; }
.source-list a {
  color: var(--text-secondary);
  text-decoration: underline;
  text-decoration-color: var(--accent);
  text-underline-offset: 3px;
  text-decoration-thickness: 1.5px;
  transition: color 0.2s;
}
.source-list a:hover { color: var(--accent-light); }
.source-org { color: var(--text-primary); font-weight: 500; }
.source-date { color: var(--text-muted); font-size: 0.8rem; }

/* PRIORITY LIST */
.priority-list { list-style: none; display: flex; flex-direction: column; gap: 0.75rem; counter-reset: priority; }
.priority-list li {
  font-size: 0.9rem;
  color: var(--text-secondary);
  padding: 0.75rem 1rem 0.75rem 3rem;
  background: var(--bg-card);
  border: 1px solid var(--border);
  border-radius: 8px;
  position: relative;
  line-height: 1.5;
  counter-increment: priority;
}
.priority-list li::before {
  content: counter(priority);
  position: absolute;
  left: 1rem;
  top: 0.75rem;
  width: 1.5rem;
  height: 1.5rem;
  background: var(--accent-glow);
  border: 1px solid var(--border-accent);
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-size: 0.7rem;
  font-weight: 700;
  color: var(--accent-light);
}

/* FOOTER */
footer { padding: 3rem 2rem; text-align: center; border-top: 1px solid var(--border); }
footer p { font-size: 0.8rem; color: var(--text-muted); }

/* RESPONSIVE */
@media (max-width: 900px) {
  .dual-track { grid-template-columns: 1fr; }
  .track-merge { display: none; }
}
@media (max-width: 768px) {
  .nav-links { display: none; }
  .card-grid.cols-3 { grid-template-columns: 1fr; }
  .card-grid.cols-2 { grid-template-columns: 1fr; }
  .hero-stats { gap: 1.5rem; }
  .hero h1 { font-size: 2.5rem; }
  .validation-card { flex-direction: column; align-items: flex-start; }
  .validation-stats { gap: 1rem; }
  .stat-row { flex-direction: column; }
  .evidence-stats { flex-direction: column; }
  section { padding: 4rem 1.25rem; }
  .data-table { font-size: 0.8rem; }
  .data-table thead th,
  .data-table tbody td { padding: 0.5rem 0.6rem; }
}
  </style>
</head>
<body>

<!-- Navigation -->
<nav>
  <a href="index.html" class="nav-logo">CyberShield Rural</a>
  <ul class="nav-links">
    <li><a href="#story">The Story</a></li>
    <li><a href="#summary">Summary</a></li>
    <li><a href="#landscape">Landscape</a></li>
    <li><a href="#funders">Funders</a></li>
    <li><a href="#strategy">Strategy</a></li>
    <li><a href="#gate">Gate Review</a></li>
    <li><a href="#sources">Sources</a></li>
  </ul>
</nav>

<!-- Hero -->
<section class="hero">
  <div class="container">
    <h1>CyberShield Rural<br><span class="gradient-text">Capital Thesis</span></h1>
    <p class="lead">12 viable funding paths identified across federal grants, state programs, venture capital, and accelerators for a healthcare cybersecurity venture targeting rural hospitals.</p>

    <div class="funnel">
      <div class="funnel-box highlight">Capital Thesis</div>
      <span class="funnel-arrow">&rarr;</span>
      <div class="funnel-box">Problem Thesis</div>
      <span class="funnel-arrow">&rarr;</span>
      <div class="funnel-box">Market Thesis</div>
      <span class="funnel-arrow">&rarr;</span>
      <div class="funnel-box">Competitive Thesis</div>
      <span class="funnel-arrow">&rarr;</span>
      <div class="funnel-box">Solution</div>
    </div>

    <div class="hero-stats">
      <div>
        <div class="hero-stat-value accent">48</div>
        <div class="hero-stat-label">Sources</div>
      </div>
      <div>
        <div class="hero-stat-value accent">15</div>
        <div class="hero-stat-label">Viable Funders</div>
      </div>
      <div>
        <div class="hero-stat-value green">38/42</div>
        <div class="hero-stat-label">Checks Passed</div>
      </div>
    </div>
  </div>
</section>

<!-- Narrative: The Story -->
<section class="narrative" id="story">
  <div class="container">

    <div class="narrative-chapter">
      <div class="narrative-num">Chapter 1 &mdash; The Opportunity</div>
      <h3>$200 million to South Carolina with explicit cybersecurity eligibility</h3>
      <p>The CMS Rural Health Transformation Program allocated <strong>$200,030,252 to South Carolina</strong> with explicit cybersecurity eligibility language under Category F: Technology and Cybersecurity Modernization (<a href="https://www.cms.gov/priorities/innovation/innovation-models/rural-health-transformation" target="_blank" class="source-link">CMS, December 2025</a>). The program represents the largest federal investment in rural health infrastructure in over a decade. No venture-backed startup dedicated exclusively to rural hospital cybersecurity was identified during the 2024&ndash;2025 research period (<a href="#sources" class="source-link">Capital thesis research, January 2026</a>). This combination&mdash;a new, large funding stream explicitly naming cybersecurity, and no existing startup positioned to capture it&mdash;defines the capital opportunity.</p>
    </div>

    <div class="narrative-divider"></div>

    <div class="narrative-chapter">
      <div class="narrative-num">Chapter 2 &mdash; The Evidence</div>
      <h3>$19.3 billion market, $18 billion in VC investment, and a state-level cybersecurity precedent</h3>
      <p>The healthcare cybersecurity market was valued at <strong>$19.3 billion in 2024</strong> and is projected to reach <strong>$75 billion by 2032</strong> at an 18.5% CAGR (<a href="https://www.fortunebusinessinsights.com/healthcare-cyber-security-market-101528" target="_blank" class="source-link">Fortune Business Insights, 2024</a>). Total cybersecurity venture capital investment reached <strong>$18 billion in 2025</strong>, up 52% year-over-year (<a href="https://www.pinpointresearch.com/cybersecurity-review-2025/" target="_blank" class="source-link">Pinpoint Search Group, January 2026</a>). At the state level, SCRA invested <strong>$250,000 equity plus a $50,000 grant</strong> in ThreatCaptain, a cybersecurity startup, and launched a <strong>Center for Cybersecurity</strong> in December 2025 (<a href="https://www.scra.org/news/scra-launches-center-for-cybersecurity/" target="_blank" class="source-link">SCRA, December 2025</a>). These data points establish that capital is flowing to both healthcare cybersecurity and South Carolina-based cybersecurity ventures.</p>
    </div>

    <div class="narrative-divider"></div>

    <div class="narrative-chapter">
      <div class="narrative-num">Chapter 3 &mdash; The Constraints</div>
      <h3>Six constraints bound the funding landscape</h3>
      <p>The capital thesis identifies six material constraints. First, <strong>RHT subaward criteria have not yet been published</strong> by SCDHHS; all RHT assessments are based on federal program language, not state implementation details (<a href="https://www.cms.gov/priorities/innovation/innovation-models/rural-health-transformation" target="_blank" class="source-link">CMS, December 2025</a>). Second, <strong>SBIR/STTR programs expired</strong> on September 30, 2025, pending Congressional reauthorization (<a href="https://www.sbir.gov/" target="_blank" class="source-link">SBIR.gov, 2025</a>). Third, <strong>SCRA membership requires a working product</strong> beyond proof-of-concept (<a href="https://www.sclaunch.com/membership-criteria" target="_blank" class="source-link">SC Launch, 2025</a>). Fourth, all VC paths require demonstrated traction. Fifth, ARPA-H viability is uncertain following reported funding cuts. Sixth, seven viable funders operate on unknown or rolling timelines, limiting planning precision.</p>
    </div>

    <div class="narrative-divider"></div>

    <div class="narrative-chapter">
      <div class="narrative-num">Chapter 4 &mdash; The Ask</div>
      <h3>38 of 42 validation checks passed with 4 warnings and 0 failures</h3>
      <p>The capital thesis passed <strong>38 of 42</strong> validation checks with <strong>4 warnings</strong> and <strong>0 failures</strong>. The warnings concern a funder count inconsistency between YAML metadata and thesis prose, and four uncited claims in the narrative. No evidence quality failures were identified. The blocking gate decision is whether the funding landscape is understood well enough to proceed to <strong>Phase 02 Problem Thesis</strong>. The <a href="#gate">Gate Review</a> section presents the evidence briefing and decision options.</p>
    </div>

    <div class="narrative-cta">
      <strong>One blocking decision.</strong> Twelve viable funding paths span federal grants, state investment, venture capital, and accelerators. Scroll to the Gate Review to see the full evidence briefing and decide whether to proceed, revise, or archive.
    </div>

  </div>
</section>

<!-- 01 / Executive Summary -->
<section id="summary">
  <div class="container">
    <div class="section-num">Section 01 / Executive Summary</div>
    <h2>Capital Landscape</h2>
    <p class="section-lead">Three categories of capital align with a healthcare cybersecurity venture targeting rural hospitals: federal grants, state investment, and an underserved market gap.</p>

    <div class="card-grid cols-3">
      <div class="card">
        <div class="card-label cyan">Federal Funding</div>
        <h3>CMS RHT Program: $200M to SC</h3>
        <p>Explicit cybersecurity language under Category F: Technology and Cybersecurity Modernization. The Tech Catalyst Fund caps startup investments at $20M per year. Grant-based funding with no equity dilution. The program is entirely new; no subawards have been issued. (CMS, December 2025)</p>
      </div>
      <div class="card">
        <div class="card-label green">State Investment</div>
        <h3>SCRA Cybersecurity Precedent</h3>
        <p>$250K equity investment plus $50K grant in ThreatCaptain (February 2025). Center for Cybersecurity launched December 2025. No healthcare cybersecurity company currently in the SCRA portfolio. $15M fund with $2.9B in follow-on capital generated since 2006. (SCRA, 2025)</p>
      </div>
      <div class="card">
        <div class="card-label purple">Market Gap</div>
        <h3>No Rural Hospital Cyber Startup</h3>
        <p>No VC-backed startup dedicated exclusively to rural hospital cybersecurity was identified during the 2024&ndash;2025 research period. The healthcare cybersecurity market is valued at $19.3B (2024) and growing at 18.5% CAGR, yet rural hospitals remain underserved. (Capital thesis research; Fortune Business Insights, 2024)</p>
      </div>
    </div>

    <div class="callout">
      <strong>Key caveat:</strong> The RHT Program is entirely new. No subawards have been issued, no projects have been funded, and state-level criteria remain unpublished. All RHT assessments in this thesis are based on federal program language, not state implementation details.
    </div>
  </div>
</section>

<!-- 02 / Funding Landscape -->
<section class="section-alt" id="landscape">
  <div class="container">
    <div class="section-num">Section 02 / Funding Landscape</div>
    <h2>Funding Landscape</h2>
    <p class="section-lead">38 funders analyzed across federal grants, state programs, venture capital, and accelerators. 15 assessed as viable for a healthcare cybersecurity venture targeting rural hospitals.</p>

    <div class="stat-row">
      <div class="stat-card">
        <div class="stat-card-value" style="color: var(--accent-light);">38</div>
        <div class="stat-card-label">Funders Analyzed</div>
      </div>
      <div class="stat-card">
        <div class="stat-card-value" style="color: var(--green);">15</div>
        <div class="stat-card-label">Viable Funders</div>
      </div>
      <div class="stat-card">
        <div class="stat-card-value" style="color: var(--cyan);">$19.3B</div>
        <div class="stat-card-label">Healthcare Cyber Market 2024</div>
      </div>
      <div class="stat-card">
        <div class="stat-card-value" style="color: var(--amber);">18.5%</div>
        <div class="stat-card-label">Market CAGR</div>
      </div>
    </div>

    <h3 style="margin-bottom: 1.25rem;">Active Funding Sources</h3>

    <div class="table-wrap">
      <table class="data-table">
        <thead>
          <tr>
            <th>Funder</th>
            <th>Type</th>
            <th>Amount</th>
            <th>Stage</th>
            <th>Viability</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td class="funder-name">CMS Rural Health Transformation</td>
            <td><span class="badge type-grant">Grant</span></td>
            <td>Up to $20M/yr</td>
            <td>Subrecipient</td>
            <td><span class="badge strong">Strong</span></td>
          </tr>
          <tr>
            <td class="funder-name">SCRA / SC Launch Inc.</td>
            <td><span class="badge type-grant">Grant</span> + <span class="badge type-equity">Equity</span></td>
            <td>$25K&ndash;$550K</td>
            <td>Post-MVP</td>
            <td><span class="badge strong">Strong</span></td>
          </tr>
          <tr>
            <td class="funder-name">ARPA-H UPGRADE/DIGIHEALS</td>
            <td><span class="badge type-grant">Grant</span></td>
            <td>$9.5M&ndash;$19M</td>
            <td>R&amp;D</td>
            <td><span class="badge moderate">Moderate</span></td>
          </tr>
          <tr>
            <td class="funder-name">ONC LEAP Grants</td>
            <td><span class="badge type-grant">Grant</span></td>
            <td>Up to $2M</td>
            <td>Various</td>
            <td><span class="badge moderate">Moderate</span></td>
          </tr>
          <tr>
            <td class="funder-name">Town Hall Ventures</td>
            <td><span class="badge type-equity">Equity</span></td>
            <td>$1M&ndash;$25M</td>
            <td>Various</td>
            <td><span class="badge strong">Strong</span></td>
          </tr>
          <tr>
            <td class="funder-name">CommonSpirit Ventures</td>
            <td><span class="badge type-equity">Equity</span></td>
            <td>Not disclosed</td>
            <td>Various</td>
            <td><span class="badge strong">Strong</span></td>
          </tr>
          <tr>
            <td class="funder-name">Flare Capital Partners</td>
            <td><span class="badge type-equity">Equity</span></td>
            <td>$1M&ndash;$8M</td>
            <td>Seed&ndash;B</td>
            <td><span class="badge moderate">Moderate</span></td>
          </tr>
          <tr>
            <td class="funder-name">Ballistic Ventures</td>
            <td><span class="badge type-equity">Equity</span></td>
            <td>Seed/Series A</td>
            <td>Seed&ndash;A</td>
            <td><span class="badge moderate">Moderate</span></td>
          </tr>
          <tr>
            <td class="funder-name">Ten Eleven Ventures</td>
            <td><span class="badge type-equity">Equity</span></td>
            <td>Stage agnostic</td>
            <td>Any</td>
            <td><span class="badge moderate">Moderate</span></td>
          </tr>
          <tr>
            <td class="funder-name">Cultivation Capital</td>
            <td><span class="badge type-equity">Equity</span></td>
            <td>$100K&ndash;$3.5M</td>
            <td>Seed&ndash;A</td>
            <td><span class="badge moderate">Moderate</span></td>
          </tr>
          <tr>
            <td class="funder-name">MassChallenge</td>
            <td><span class="badge type-accel">Accelerator</span></td>
            <td>Prizes (zero equity)</td>
            <td>Early</td>
            <td><span class="badge strong">Strong</span></td>
          </tr>
          <tr>
            <td class="funder-name">MACH37</td>
            <td><span class="badge type-accel">Accelerator</span></td>
            <td>5% equity</td>
            <td>Early</td>
            <td><span class="badge strong">Strong</span></td>
          </tr>
          <tr>
            <td class="funder-name">Health Wildcatters</td>
            <td><span class="badge type-accel">Accelerator</span></td>
            <td>$30K&ndash;$380K (8%)</td>
            <td>Early</td>
            <td><span class="badge moderate">Moderate</span></td>
          </tr>
          <tr>
            <td class="funder-name">MUSC Zucker Institute</td>
            <td><span class="badge type-support">Support</span></td>
            <td>Varies</td>
            <td>Various</td>
            <td><span class="badge moderate">Moderate</span></td>
          </tr>
        </tbody>
      </table>
    </div>
  </div>
</section>

<!-- 03 / Funder Deep Dives -->
<section id="funders">
  <div class="container">
    <div class="section-num">Section 03 / Funder Deep Dives</div>
    <h2>Funder Deep Dives</h2>
    <p class="section-lead">Detailed analysis of the seven highest-priority funding paths, including alignment strengths, gaps, and timeline considerations.</p>

    <div class="accordion">

      <!-- CMS RHT -->
      <div class="accordion-item open">
        <div class="accordion-header">
          <div class="accordion-header-left">
            <h3>CMS Rural Health Transformation</h3>
            <span class="badge strong">Strong</span>
          </div>
          <span class="accordion-arrow">&#9660;</span>
        </div>
        <div class="accordion-content">
          <div class="accordion-body">
            <p>The CMS Rural Health Transformation Program is a $50 billion, five-year federal initiative representing the largest investment in rural health infrastructure in over a decade. South Carolina received $200,030,252 in allocations. Category F explicitly names Technology and Cybersecurity Modernization as an eligible investment area. The Tech Catalyst Fund caps individual startup investments at $20M per year. (CMS, December 2025)</p>
            <h4>Key Criteria</h4>
            <ul class="criteria-list">
              <li>Must be a subrecipient through SCDHHS (state Medicaid agency administers funds)</li>
              <li>Category F: Technology and Cybersecurity Modernization eligible</li>
              <li>Tech Catalyst Fund: capped at $20M/year for startup investments</li>
              <li>Requires demonstrated alignment with rural health outcomes</li>
              <li>Sustainability plan required beyond grant period</li>
            </ul>
            <h4>Alignment Strengths</h4>
            <ul class="alignment-list">
              <li class="strength">Explicit cybersecurity language in Category F eligibility criteria</li>
              <li class="strength">$200M allocation to South Carolina specifically</li>
              <li class="strength">Grant-based: no equity dilution</li>
              <li class="strength">Multi-year funding provides runway stability</li>
            </ul>
            <h4>Alignment Gaps</h4>
            <ul class="alignment-list">
              <li class="gap-item blocker">Subaward criteria not yet published by SCDHHS (blocking)</li>
              <li class="gap-item">Needs rural hospital partner as subrecipient sponsor (significant)</li>
              <li class="gap-item">Sustainability plan required beyond grant period (significant)</li>
            </ul>
            <p><span class="criteria-source">Timeline: Subaward criteria expected 2026. No fixed application deadline published.</span></p>
          </div>
        </div>
      </div>

      <!-- SCRA -->
      <div class="accordion-item">
        <div class="accordion-header">
          <div class="accordion-header-left">
            <h3>SCRA / SC Launch Inc.</h3>
            <span class="badge strong">Strong</span>
          </div>
          <span class="accordion-arrow">&#9660;</span>
        </div>
        <div class="accordion-content">
          <div class="accordion-body">
            <p>SCRA operates SC Launch, a $15 million fund that has generated $2.9 billion in follow-on capital since 2006. In February 2025, SCRA invested $250,000 equity plus a $50,000 grant in ThreatCaptain, a cybersecurity startup. In December 2025, SCRA launched a Center for Cybersecurity, signaling strategic priority for the sector. No healthcare cybersecurity company is currently in the SCRA portfolio. (SCRA, 2025)</p>
            <h4>Key Criteria</h4>
            <ul class="criteria-list">
              <li>SC Launch membership requires working product beyond proof-of-concept</li>
              <li>Investment range: $25K&ndash;$550K (grants and equity)</li>
              <li>Company must be incorporated in or relocating to South Carolina</li>
              <li>Acceptance rate below 40%</li>
            </ul>
            <h4>Alignment Strengths</h4>
            <ul class="alignment-list">
              <li class="strength">Demonstrated cybersecurity investment precedent (ThreatCaptain)</li>
              <li class="strength">Center for Cybersecurity launched December 2025</li>
              <li class="strength">No healthcare cybersecurity company in current portfolio</li>
              <li class="strength">$2.9B follow-on capital track record signals credibility to later investors</li>
            </ul>
            <h4>Alignment Gaps</h4>
            <ul class="alignment-list">
              <li class="gap-item blocker">Requires working product beyond POC (blocking)</li>
              <li class="gap-item">Below 40% acceptance rate (significant)</li>
            </ul>
            <p><span class="criteria-source">Timeline: Rolling applications. Product readiness is the gating factor.</span></p>
          </div>
        </div>
      </div>

      <!-- Town Hall Ventures -->
      <div class="accordion-item">
        <div class="accordion-header">
          <div class="accordion-header-left">
            <h3>Town Hall Ventures</h3>
            <span class="badge strong">Strong</span>
          </div>
          <span class="accordion-arrow">&#9660;</span>
        </div>
        <div class="accordion-content">
          <div class="accordion-body">
            <p>Town Hall Ventures invests $1M&ndash;$25M across stages in companies serving underserved populations. The firm was co-founded by Andy Slavitt, former Acting Administrator of CMS, providing deep federal healthcare policy expertise. The fund thesis explicitly targets healthcare access for rural and underserved communities. (Town Hall Ventures, 2025)</p>
            <h4>Key Criteria</h4>
            <ul class="criteria-list">
              <li>Companies serving underserved populations, including rural communities</li>
              <li>Healthcare and government-adjacent technology</li>
              <li>Investment range: $1M&ndash;$25M across stages</li>
            </ul>
            <h4>Alignment Strengths</h4>
            <ul class="alignment-list">
              <li class="strength">Explicit focus on underserved populations including rural</li>
              <li class="strength">Former CMS Administrator as co-founder (federal alignment)</li>
              <li class="strength">Flexible stage and check size</li>
            </ul>
            <h4>Alignment Gaps</h4>
            <ul class="alignment-list">
              <li class="gap-item">Requires demonstrated traction (significant)</li>
            </ul>
            <p><span class="criteria-source">Timeline: Rolling. Traction required before engagement.</span></p>
          </div>
        </div>
      </div>

      <!-- CommonSpirit Ventures -->
      <div class="accordion-item">
        <div class="accordion-header">
          <div class="accordion-header-left">
            <h3>CommonSpirit Ventures</h3>
            <span class="badge strong">Strong</span>
          </div>
          <span class="accordion-arrow">&#9660;</span>
        </div>
        <div class="accordion-content">
          <div class="accordion-body">
            <p>CommonSpirit Health Ventures is a $250 million strategic venture fund backed by CommonSpirit Health, one of the largest nonprofit health systems in the United States. The fund has made 36 investments to date. CommonSpirit operates Critical Access Hospitals in 21 states, providing a potential pathway to pilot deployment and customer acquisition. (CommonSpirit Ventures, 2025)</p>
            <h4>Key Criteria</h4>
            <ul class="criteria-list">
              <li>Strategic alignment with CommonSpirit Health system needs</li>
              <li>Healthcare technology focus</li>
              <li>Amount not publicly disclosed per deal</li>
            </ul>
            <h4>Alignment Strengths</h4>
            <ul class="alignment-list">
              <li class="strength">Operates Critical Access Hospitals in 21 states (built-in customer base)</li>
              <li class="strength">$250M fund with 36 investments (active deployer)</li>
              <li class="strength">Strategic investor: can provide both capital and customers</li>
            </ul>
            <h4>Alignment Gaps</h4>
            <ul class="alignment-list">
              <li class="gap-item">No cybersecurity investments identified in current portfolio (significant)</li>
              <li class="gap-item">Requires product maturity for strategic evaluation (significant)</li>
            </ul>
            <p><span class="criteria-source">Timeline: Rolling. Product maturity and strategic fit drive timing.</span></p>
          </div>
        </div>
      </div>

      <!-- ARPA-H -->
      <div class="accordion-item">
        <div class="accordion-header">
          <div class="accordion-header-left">
            <h3>ARPA-H UPGRADE/DIGIHEALS</h3>
            <span class="badge moderate">Moderate</span>
          </div>
          <span class="accordion-arrow">&#9660;</span>
        </div>
        <div class="accordion-content">
          <div class="accordion-body">
            <p>ARPA-H has deployed over $100 million through the UPGRADE and DIGIHEALS programs targeting healthcare cybersecurity. Individual awards range from $9.5M to $19M. The programs fund research and development of novel cybersecurity tools for healthcare infrastructure. However, ARPA-H has faced reported funding cuts, and the programs have historically favored academic and established research institutions. (ARPA-H, 2024&ndash;2025)</p>
            <h4>Key Criteria</h4>
            <ul class="criteria-list">
              <li>Novel R&amp;D approach to healthcare cybersecurity</li>
              <li>Award range: $9.5M&ndash;$19M per project</li>
              <li>Open to commercial entities, academic institutions, and nonprofits</li>
            </ul>
            <h4>Alignment Strengths</h4>
            <ul class="alignment-list">
              <li class="strength">Large award sizes ($9.5M&ndash;$19M) provide substantial runway</li>
              <li class="strength">Directly targets healthcare cybersecurity</li>
              <li class="strength">Non-dilutive grant funding</li>
            </ul>
            <h4>Alignment Gaps</h4>
            <ul class="alignment-list">
              <li class="gap-item blocker">R&amp;D requirements may not align with product-stage company (blocking)</li>
              <li class="gap-item blocker">Funding cuts introduce viability uncertainty (blocking)</li>
              <li class="gap-item">Historical bias toward academic and established institutions (significant)</li>
            </ul>
            <p><span class="criteria-source">Timeline: Program status uncertain due to reported funding cuts. Monitor only.</span></p>
          </div>
        </div>
      </div>

      <!-- VC Cluster -->
      <div class="accordion-item">
        <div class="accordion-header">
          <div class="accordion-header-left">
            <h3>Venture Capital Cluster</h3>
            <span class="badge moderate">Moderate</span>
          </div>
          <span class="accordion-arrow">&#9660;</span>
        </div>
        <div class="accordion-content">
          <div class="accordion-body">
            <p>Four venture capital firms with relevant thesis overlap were identified. <strong>Flare Capital Partners</strong> ($1B AUM) invested in ClearDATA, a healthcare cloud security company, establishing healthcare cybersecurity precedent. <strong>Ballistic Ventures</strong> ($600M+ fund) is a cybersecurity-only firm investing at Seed and Series A. <strong>Ten Eleven Ventures</strong> ($1B+ AUM) invested in Anatomy IT, a healthcare-focused managed services provider. <strong>Cultivation Capital</strong> operates dual cybersecurity and healthcare funds ($100K&ndash;$3.5M checks). All four require demonstrated traction before engagement.</p>
            <h4>Key Criteria</h4>
            <ul class="criteria-list">
              <li>Flare Capital: $1M&ndash;$8M, healthcare IT focus, Seed through Series B</li>
              <li>Ballistic Ventures: Cybersecurity-only, Seed and Series A, operator-founded</li>
              <li>Ten Eleven Ventures: Cybersecurity-focused, stage agnostic, $1B+ under management</li>
              <li>Cultivation Capital: $100K&ndash;$3.5M, dual cybersecurity + healthcare funds, Seed to Series A</li>
            </ul>
            <h4>Alignment Strengths</h4>
            <ul class="alignment-list">
              <li class="strength">Portfolio precedents in healthcare cybersecurity (Flare: ClearDATA; Ten Eleven: Anatomy IT)</li>
              <li class="strength">Cybersecurity-dedicated funds (Ballistic, Ten Eleven) understand the sector</li>
              <li class="strength">Cultivation Capital uniquely spans both cybersecurity and healthcare</li>
            </ul>
            <h4>Alignment Gaps</h4>
            <ul class="alignment-list">
              <li class="gap-item">All require demonstrated traction: revenue, customers, or LOIs (significant)</li>
              <li class="gap-item">Rolling processes with no fixed deadlines; timing uncertain (significant)</li>
            </ul>
            <p><span class="criteria-source">Timeline: All operate rolling processes. Engagement appropriate post-Phase 12 (customer traction).</span></p>
          </div>
        </div>
      </div>

      <!-- Accelerators -->
      <div class="accordion-item">
        <div class="accordion-header">
          <div class="accordion-header-left">
            <h3>Accelerators</h3>
            <span class="badge strong">Strong</span>
          </div>
          <span class="accordion-arrow">&#9660;</span>
        </div>
        <div class="accordion-content">
          <div class="accordion-body">
            <p>Three accelerators offer distinct value propositions for an early-stage healthcare cybersecurity venture. <strong>MassChallenge</strong> is a zero-equity accelerator offering prize funding and dual-track eligibility (HealthTech and Cybersecurity). <strong>MACH37</strong> is a cybersecurity-focused accelerator with 94 graduates, 83% company survival rate, 64% funded rate, and takes 5% equity. <strong>Health Wildcatters</strong> is a healthcare-focused accelerator offering $30K&ndash;$380K for 8% equity, ranked among top healthcare accelerators nationally.</p>
            <h4>Key Criteria</h4>
            <ul class="criteria-list">
              <li>MassChallenge: Zero equity, prizes up to $100K+, dual-track HealthTech + Cybersecurity, application deadline April 2026</li>
              <li>MACH37: 5% equity, cybersecurity-focused, 90-day program, Virginia-based</li>
              <li>Health Wildcatters: $30K&ndash;$380K for 8% equity, healthcare-focused, Dallas-based</li>
            </ul>
            <h4>Alignment Strengths</h4>
            <ul class="alignment-list">
              <li class="strength">MassChallenge: zero equity model preserves ownership; dual-track eligibility</li>
              <li class="strength">MACH37: 83% survival rate and 64% funded rate demonstrate track record</li>
              <li class="strength">Health Wildcatters: healthcare domain expertise and top-ranked program</li>
              <li class="strength">All three accept early-stage companies</li>
            </ul>
            <h4>Alignment Gaps</h4>
            <ul class="alignment-list">
              <li class="gap-item">MACH37 and Health Wildcatters require equity (5% and 8% respectively)</li>
              <li class="gap-item">Geographic requirements may apply (MACH37: Virginia; Health Wildcatters: Dallas)</li>
            </ul>
            <p><span class="criteria-source">Timeline: MassChallenge application deadline April 2026. MACH37 and Health Wildcatters operate cohort-based cycles.</span></p>
          </div>
        </div>
      </div>

    </div>
  </div>
</section>

<!-- 04 / Alignment Strategy -->
<section class="section-alt" id="strategy">
  <div class="container">
    <div class="section-num">Section 04 / Alignment Strategy</div>
    <h2>Alignment Strategy</h2>
    <p class="section-lead">Ten priority actions, seven phase dependencies, and a funding timeline map the path from current state to capital readiness.</p>

    <h3 style="margin-bottom: 1.25rem;">Priority Actions</h3>

    <ol class="priority-list">
      <li>Subscribe to SCDHHS Medicaid Bulletins to monitor RHT subaward criteria publication</li>
      <li>Build working product beyond proof-of-concept (required for SCRA, all VCs, most accelerators)</li>
      <li>Secure rural hospital letter of intent (required for RHT, Town Hall, CommonSpirit)</li>
      <li>Apply for SCRA Membership once product readiness is achieved</li>
      <li>Develop sustainability narrative for grant-based funders (RHT, SCRA)</li>
      <li>Establish advisory board with healthcare cybersecurity and rural health expertise</li>
      <li>Prepare IP strategy documentation (required for SCRA, Ballistic, Ten Eleven)</li>
      <li>Apply to MassChallenge HealthTech + Cybersecurity dual track (April 2026 deadline)</li>
      <li>Enroll in 3Phase for SBIR/STTR readiness when programs are reauthorized</li>
      <li>Build VC pitch materials with traction data post-Phase 12</li>
    </ol>

    <h3 style="margin-top: 3rem; margin-bottom: 1.25rem;">Phase Dependencies</h3>

    <div class="table-wrap">
      <table class="data-table">
        <thead>
          <tr>
            <th>Gap</th>
            <th>Resolution Phase</th>
            <th>Funders Affected</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td class="funder-name">No working product</td>
            <td>Phase 11 (MVP Build)</td>
            <td>SCRA, all VCs, most accelerators</td>
          </tr>
          <tr>
            <td class="funder-name">No rural hospital partner</td>
            <td>Phase 12 (Customer Traction)</td>
            <td>RHT, Town Hall, CommonSpirit</td>
          </tr>
          <tr>
            <td class="funder-name">No sustainability model</td>
            <td>Phase 06 (Business Thesis)</td>
            <td>RHT, SCRA</td>
          </tr>
          <tr>
            <td class="funder-name">No IP strategy</td>
            <td>Phase 05 (Solution Thesis)</td>
            <td>SCRA, Ballistic, Ten Eleven</td>
          </tr>
          <tr>
            <td class="funder-name">No advisory board</td>
            <td>Phase 05&ndash;06</td>
            <td>SCRA, all VCs</td>
          </tr>
          <tr>
            <td class="funder-name">RHT subaward criteria unknown</td>
            <td>External (SCDHHS)</td>
            <td>RHT</td>
          </tr>
          <tr>
            <td class="funder-name">SBIR/STTR expired</td>
            <td>External (Congress)</td>
            <td>SBIR, 3Phase</td>
          </tr>
        </tbody>
      </table>
    </div>

    <h3 style="margin-top: 3rem; margin-bottom: 1.25rem;">Funding Timeline</h3>

    <div class="table-wrap">
      <table class="data-table">
        <thead>
          <tr>
            <th>Funder</th>
            <th>Next Deadline</th>
            <th>Decision Timeline</th>
            <th>Readiness</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td class="funder-name">MassChallenge</td>
            <td>April 2026</td>
            <td>Summer 2026</td>
            <td><span class="badge not-ready">Not Ready</span></td>
          </tr>
          <tr>
            <td class="funder-name">MACH37</td>
            <td>Cohort-based (TBD)</td>
            <td>Rolling cohort admission</td>
            <td><span class="badge not-ready">Not Ready</span></td>
          </tr>
          <tr>
            <td class="funder-name">Health Wildcatters</td>
            <td>Cohort-based (TBD)</td>
            <td>Rolling cohort admission</td>
            <td><span class="badge not-ready">Not Ready</span></td>
          </tr>
          <tr>
            <td class="funder-name">SCRA / SC Launch</td>
            <td>Rolling</td>
            <td>60&ndash;90 days from application</td>
            <td><span class="badge not-ready">Not Ready</span></td>
          </tr>
          <tr>
            <td class="funder-name">CMS RHT Program</td>
            <td>TBD (subaward criteria pending)</td>
            <td>TBD</td>
            <td><span class="badge not-ready">Not Ready</span></td>
          </tr>
          <tr>
            <td class="funder-name">ONC LEAP Grants</td>
            <td>TBD</td>
            <td>TBD</td>
            <td><span class="badge not-ready">Not Ready</span></td>
          </tr>
          <tr>
            <td class="funder-name">Town Hall Ventures</td>
            <td>Rolling</td>
            <td>Rolling</td>
            <td><span class="badge not-ready">Not Ready</span></td>
          </tr>
          <tr>
            <td class="funder-name">CommonSpirit Ventures</td>
            <td>Rolling</td>
            <td>Rolling</td>
            <td><span class="badge not-ready">Not Ready</span></td>
          </tr>
          <tr>
            <td class="funder-name">Flare Capital</td>
            <td>Rolling</td>
            <td>Rolling</td>
            <td><span class="badge not-ready">Not Ready</span></td>
          </tr>
          <tr>
            <td class="funder-name">Ballistic Ventures</td>
            <td>Rolling</td>
            <td>Rolling</td>
            <td><span class="badge not-ready">Not Ready</span></td>
          </tr>
          <tr>
            <td class="funder-name">Ten Eleven Ventures</td>
            <td>Rolling</td>
            <td>Rolling</td>
            <td><span class="badge not-ready">Not Ready</span></td>
          </tr>
          <tr>
            <td class="funder-name">Cultivation Capital</td>
            <td>Rolling</td>
            <td>Rolling</td>
            <td><span class="badge not-ready">Not Ready</span></td>
          </tr>
          <tr>
            <td class="funder-name">ARPA-H</td>
            <td>TBD</td>
            <td>TBD</td>
            <td><span class="badge suspended">Suspended</span></td>
          </tr>
          <tr>
            <td class="funder-name">SBIR/STTR</td>
            <td>Expired (pending reauthorization)</td>
            <td>N/A</td>
            <td><span class="badge suspended">Suspended</span></td>
          </tr>
        </tbody>
      </table>
    </div>
  </div>
</section>

<!-- 05 / Gate Review -->
<section id="gate">
  <div class="container">
    <div class="section-num">Section 05 / Gate Review</div>
    <h2>Gate Review</h2>
    <p class="section-lead">Evidence briefing, validation results, and pending decisions for the Capital Thesis phase.</p>

    <!-- Evidence Briefing -->
    <div class="evidence-briefing">
      <h3>Evidence Briefing</h3>

      <div class="briefing-stats">
        <div class="briefing-stat">
          <span class="briefing-stat-value">38</span>
          <span class="briefing-stat-label">Funders Analyzed</span>
        </div>
        <div class="briefing-stat">
          <span class="briefing-stat-value">15</span>
          <span class="briefing-stat-label">Viable Funders</span>
        </div>
        <div class="briefing-stat">
          <span class="briefing-stat-value">48</span>
          <span class="briefing-stat-label">Sources</span>
        </div>
        <div class="briefing-stat">
          <span class="briefing-stat-value">93%</span>
          <span class="briefing-stat-label">Citation Coverage</span>
        </div>
      </div>

      <div class="briefing-columns">
        <div class="briefing-column">
          <h4 class="briefing-strong">What's Strong</h4>
          <ul class="briefing-list strong">
            <li>Deep federal funding alignment: CMS RHT Program explicitly names cybersecurity under Category F</li>
            <li>State-level cybersecurity investment precedent: SCRA invested in ThreatCaptain and launched Center for Cybersecurity</li>
            <li>Multiple independent funding tracks: 15 viable funders across 4 categories (grants, equity, accelerators, support)</li>
            <li>Rigorous counter-evidence treatment: 3 counter-signals documented and analyzed</li>
            <li>Strong writing governance: 0 prohibited word violations across the thesis</li>
          </ul>
        </div>
        <div class="briefing-column">
          <h4 class="briefing-weak">What's Weak or Unresolved</h4>
          <ul class="briefing-list weak">
            <li>Funder count inconsistency: YAML metadata says 38 analyzed / 15 viable; thesis prose says 35 analyzed / 12 viable</li>
            <li>RHT Program is entirely new: no subawards issued, no projects funded, state-level criteria unpublished</li>
            <li>7 viable funders have unknown timelines (VCs with rolling processes reduce planning precision)</li>
            <li>All VC and SCRA paths require working product or demonstrated traction</li>
            <li>ARPA-H viability uncertain after reported funding cuts</li>
          </ul>
        </div>
      </div>
    </div>

    <!-- Validation Summary -->
    <div class="validation-card needs-revision">
      <div class="validation-status">
        <div class="validation-icon amber-icon">&#9888;</div>
        <div class="validation-text">
          <h3>Ready for Gate Review with Warnings</h3>
          <p>38 checks passed, 4 warnings, 0 failures. Warnings are documentation issues, not evidence gaps.</p>
        </div>
      </div>
      <div class="validation-stats">
        <div class="validation-stat">
          <div class="validation-stat-value" style="color: var(--green);">38</div>
          <div class="validation-stat-label">Passed</div>
        </div>
        <div class="validation-stat">
          <div class="validation-stat-value" style="color: var(--amber);">4</div>
          <div class="validation-stat-label">Warnings</div>
        </div>
        <div class="validation-stat">
          <div class="validation-stat-value" style="color: var(--green);">0</div>
          <div class="validation-stat-label">Failed</div>
        </div>
      </div>
    </div>

    <!-- Blocking Decision -->
    <h3 class="gate-group-label">Blocking Decision</h3>
    <p class="gate-group-desc">Must be resolved before the next phase can start.</p>
    <div class="gate-cards">
      <div class="gate-card blocking">
        <div class="gate-card-header">
          <div class="gate-num">1</div>
          <div class="gate-question">Do we understand what funders want and can we align to it?</div>
          <span class="gate-priority blocking">Blocking</span>
        </div>
        <p class="gate-context">The capital thesis identified 15 viable funders across federal grants, state programs, venture capital, and accelerators. Deep dives on 7 highest-priority funders document specific criteria, alignment strengths, and gaps. The RHT Program provides the strongest single opportunity ($200M to SC with explicit cybersecurity language) but subaward criteria remain unpublished. All paths require product and/or traction milestones that map to later Venture Forge phases.</p>
        <div class="gate-options">
          <div class="gate-option">
            <strong>Proceed</strong> &mdash; Start Phase 02 Problem Thesis. <span class="gate-consequence">&rarr; Research validates whether the rural hospital cybersecurity problem is real, severe, and underserved. Capital alignment informs which problem dimensions to emphasize.</span>
          </div>
          <div class="gate-option">
            <strong>Revise</strong> &mdash; Fix funder count mismatch and 4 uncited claims. <span class="gate-consequence">&rarr; Reconcile YAML (38/15) with prose (35/12), add missing citations. Estimated scope: 2&ndash;3 hours. Core analysis does not change.</span>
          </div>
          <div class="gate-option">
            <strong>Kill</strong> &mdash; Archive CyberShield Rural. <span class="gate-consequence">&rarr; Capital thesis data (48 sources, 15 viable funders, 7 deep dives) preserved in phases/01-capital/ for reference. A kill decision would reflect strategic prioritization.</span>
          </div>
        </div>
      </div>
    </div>

    <!-- Strategic Decisions -->
    <h3 class="gate-group-label">Strategic Decisions</h3>
    <p class="gate-group-desc">Inform strategy but do not block the next phase. Later phases will produce data that makes these choices clearer.</p>
    <div class="gate-cards">
      <div class="gate-card strategic">
        <div class="gate-card-header">
          <div class="gate-num">2</div>
          <div class="gate-question">Which funding track to prioritize?</div>
          <span class="gate-priority strategic">Strategic</span>
        </div>
        <p class="gate-revisit">Revisit after Phase 06 &mdash; Business Thesis will model revenue scenarios against each funding track.</p>
        <p class="gate-context">Three tracks offer distinct risk/reward profiles. Grant-first (RHT + SCRA) provides non-dilutive capital but depends on unpublished criteria and product readiness. Accelerator-first (MassChallenge/MACH37) provides structure, mentorship, and credibility but may require relocation. Parallel approach maximizes optionality but increases operational complexity.</p>
        <div class="gate-options">
          <div class="gate-option">
            <strong>Grant-first (RHT + SCRA)</strong> <span class="gate-consequence">&rarr; Non-dilutive path. Requires SCDHHS criteria publication and working product. Highest potential award sizes.</span>
          </div>
          <div class="gate-option">
            <strong>Accelerator-first (MassChallenge/MACH37)</strong> <span class="gate-consequence">&rarr; Structured path. MassChallenge zero-equity model preserves ownership. MACH37 provides cybersecurity network. Earliest possible entry: April 2026 application.</span>
          </div>
          <div class="gate-option">
            <strong>Parallel approach</strong> <span class="gate-consequence">&rarr; Apply to accelerators while monitoring RHT criteria and building product for SCRA. Maximizes optionality at cost of focus.</span>
          </div>
        </div>
      </div>

      <div class="gate-card strategic">
        <div class="gate-card-header">
          <div class="gate-num">3</div>
          <div class="gate-question">How to handle the ARPA-H uncertainty?</div>
          <span class="gate-priority strategic">Strategic</span>
        </div>
        <p class="gate-revisit">Revisit after Phase 05 &mdash; Solution Thesis will determine whether R&amp;D framing aligns with product direction.</p>
        <p class="gate-context">ARPA-H UPGRADE/DIGIHEALS programs offer large awards ($9.5M&ndash;$19M) but face two blocking gaps: R&amp;D requirements may not align with a product-stage company, and reported funding cuts introduce program viability uncertainty. The academic bias in historical awards is a significant but not blocking concern.</p>
        <div class="gate-options">
          <div class="gate-option">
            <strong>Pursue</strong> <span class="gate-consequence">&rarr; Frame solution with R&amp;D component. High reward, high effort, uncertain viability.</span>
          </div>
          <div class="gate-option">
            <strong>Deprioritize</strong> <span class="gate-consequence">&rarr; Focus on grant and accelerator tracks with clearer paths. Revisit if ARPA-H stabilizes.</span>
          </div>
          <div class="gate-option">
            <strong>Monitor only</strong> <span class="gate-consequence">&rarr; Track ARPA-H program status without investing preparation effort. Re-evaluate at Phase 05.</span>
          </div>
        </div>
      </div>

      <div class="gate-card strategic">
        <div class="gate-card-header">
          <div class="gate-num">4</div>
          <div class="gate-question">When to approach VC investors?</div>
          <span class="gate-priority strategic">Strategic</span>
        </div>
        <p class="gate-revisit">Revisit after Phase 12 &mdash; Customer Traction will determine readiness for VC engagement.</p>
        <p class="gate-context">All four identified VC firms (Flare Capital, Ballistic Ventures, Ten Eleven Ventures, Cultivation Capital) require demonstrated traction. Total cybersecurity VC investment reached $18B in 2025 (up 52% YoY), indicating strong market appetite. Premature VC engagement risks burning relationships without adequate proof points.</p>
        <div class="gate-options">
          <div class="gate-option">
            <strong>Post-Phase 12</strong> <span class="gate-consequence">&rarr; Approach VCs with customer traction (LOIs, revenue, or pilot data). Standard path: accelerator graduation or SCRA validation as credibility signal.</span>
          </div>
          <div class="gate-option">
            <strong>Post-accelerator</strong> <span class="gate-consequence">&rarr; Use accelerator graduation (MACH37 64% funded rate) as warm introduction mechanism. Adds 3&ndash;6 months but provides network and credibility.</span>
          </div>
        </div>
      </div>
    </div>
  </div>
</section>

<!-- 06 / Sources -->
<section class="section-alt" id="sources">
  <div class="container">
    <div class="section-num">Section 06 / Sources</div>
    <h2>Sources</h2>
    <p class="section-lead">48 unique sources organized by category. All sources used in the Capital Thesis are listed below with organization, document title, date, and URL where available.</p>

    <div class="sources-grid">

      <div class="source-category">
        <h3>Government Sources (13)</h3>
        <ul class="source-list">
          <li>
            <span class="source-org">CMS</span> &mdash; Rural Health Transformation Model overview and state allocations
            <span class="source-date">(December 2025)</span><br>
            <a href="https://www.cms.gov/priorities/innovation/innovation-models/rural-health-transformation" target="_blank">cms.gov</a> &mdash; Cited for: $50B program, SC $200M allocation, Category F cybersecurity eligibility, Tech Catalyst Fund $20M/yr cap
          </li>
          <li>
            <span class="source-org">CMS</span> &mdash; Tech Catalyst Fund guidelines
            <span class="source-date">(December 2025)</span><br>
            <a href="https://www.cms.gov/priorities/innovation/innovation-models/rural-health-transformation" target="_blank">cms.gov</a> &mdash; Cited for: Startup investment cap, eligibility criteria
          </li>
          <li>
            <span class="source-org">ARPA-H</span> &mdash; UPGRADE Program and DIGIHEALS initiative
            <span class="source-date">(2024&ndash;2025)</span><br>
            <a href="https://arpa-h.gov/" target="_blank">arpa-h.gov</a> &mdash; Cited for: $100M+ deployed, $9.5M&ndash;$19M award sizes, healthcare cybersecurity focus
          </li>
          <li>
            <span class="source-org">ONC</span> &mdash; Leading Edge Acceleration Projects (LEAP) grant program
            <span class="source-date">(2024&ndash;2025)</span><br>
            <a href="https://www.healthit.gov/topic/onc-funding-opportunities" target="_blank">healthit.gov</a> &mdash; Cited for: Up to $2M awards, health IT interoperability and security focus
          </li>
          <li>
            <span class="source-org">SBIR.gov</span> &mdash; SBIR/STTR program status and reauthorization
            <span class="source-date">(2025)</span><br>
            <a href="https://www.sbir.gov/" target="_blank">sbir.gov</a> &mdash; Cited for: Program expiration September 30, 2025; pending Congressional reauthorization
          </li>
          <li>
            <span class="source-org">SCDHHS</span> &mdash; South Carolina Department of Health and Human Services (Medicaid agency)
            <span class="source-date">(2025&ndash;2026)</span><br>
            Cited for: Subaward criteria pending publication; state-level RHT implementation
          </li>
          <li>
            <span class="source-org">HHS</span> &mdash; HIPAA Security Rule proposed update (Federal Register Document 2024-30983)
            <span class="source-date">(January 2025)</span><br>
            <a href="https://www.federalregister.gov/documents/2025/01/06/2024-30983/hipaa-security-rule-to-strengthen-the-cybersecurity-of-electronic-protected-health-information" target="_blank">federalregister.gov</a> &mdash; Cited for: $9B first-year compliance cost estimate
          </li>
          <li>
            <span class="source-org">CISA</span> &mdash; Cybersecurity Performance Goals adoption report
            <span class="source-date">(October 2024)</span><br>
            Cited for: Fewer than 400 healthcare participants in Cyber Hygiene Services
          </li>
          <li>
            <span class="source-org">White House / ONCD</span> &mdash; National Cybersecurity Strategy
            <span class="source-date">(2023&ndash;2025)</span><br>
            Cited for: Healthcare designated critical infrastructure; federal cybersecurity investment priorities
          </li>
          <li>
            <span class="source-org">FCC</span> &mdash; Universal Service Fund and rural broadband programs
            <span class="source-date">(2024&ndash;2025)</span><br>
            Cited for: Rural connectivity infrastructure relevant to cybersecurity deployment
          </li>
          <li>
            <span class="source-org">NIST</span> &mdash; Cybersecurity Framework and healthcare implementation guidance
            <span class="source-date">(2024)</span><br>
            Cited for: Standards referenced by multiple funders as compliance baseline
          </li>
          <li>
            <span class="source-org">GAO</span> &mdash; Reports on healthcare cybersecurity and rural hospital financial viability
            <span class="source-date">(2023&ndash;2025)</span><br>
            Cited for: Federal oversight perspective on rural health funding
          </li>
          <li>
            <span class="source-org">HRSA</span> &mdash; Federal Office of Rural Health Policy; Rural Health Clinic and CAH designations
            <span class="source-date">(2024&ndash;2025)</span><br>
            Cited for: Rural hospital classification criteria and federal support programs
          </li>
        </ul>
      </div>

      <div class="source-category">
        <h3>Industry and Research Sources (7)</h3>
        <ul class="source-list">
          <li>
            <span class="source-org">Fortune Business Insights</span> &mdash; Healthcare Cybersecurity Market report
            <span class="source-date">(2024)</span><br>
            <a href="https://www.fortunebusinessinsights.com/healthcare-cyber-security-market-101528" target="_blank">fortunebusinessinsights.com</a> &mdash; Cited for: $19.3B market value (2024), $75B projected (2032), 18.5% CAGR
          </li>
          <li>
            <span class="source-org">Pinpoint Search Group</span> &mdash; "Cybersecurity Review 2025" annual report
            <span class="source-date">(January 2026)</span><br>
            <a href="https://www.pinpointresearch.com/cybersecurity-review-2025/" target="_blank">pinpointresearch.com</a> &mdash; Cited for: $18B total cybersecurity VC investment in 2025, 52% YoY growth
          </li>
          <li>
            <span class="source-org">Momentum Cyber</span> &mdash; Annual Cybersecurity Almanac
            <span class="source-date">(2025)</span><br>
            Cited for: Cybersecurity M&amp;A and investment trends; sector deal flow data
          </li>
          <li>
            <span class="source-org">PitchBook / NVCA</span> &mdash; Venture capital healthcare and cybersecurity deal data
            <span class="source-date">(2024&ndash;2025)</span><br>
            Cited for: Healthcare IT and cybersecurity investment volume and stage distribution
          </li>
          <li>
            <span class="source-org">CB Insights</span> &mdash; Healthcare cybersecurity startup landscape
            <span class="source-date">(2024&ndash;2025)</span><br>
            Cited for: Competitive landscape analysis; no rural-dedicated cybersecurity startup identified
          </li>
          <li>
            <span class="source-org">Black Book Research</span> &mdash; Survey of 187 small/rural hospital leaders
            <span class="source-date">(June 2025)</span><br>
            <a href="https://www.beckershospitalreview.com/healthcare-information-technology/cybersecurity/cybersecurity-takes-back-seat-at-rural-hospitals-facing-medicaid-cuts-report/" target="_blank">beckershospitalreview.com</a> &mdash; Cited for: 73% lack adequate defenses; 92% cybersecurity tools underutilized
          </li>
          <li>
            <span class="source-org">Chartis Center for Rural Health</span> &mdash; "2025 Rural Health State of the State"
            <span class="source-date">(February 2025)</span><br>
            <a href="https://www.chartis.com/insights/2025-rural-health-state-state" target="_blank">chartis.com</a> &mdash; Cited for: 46% negative margins; 432 vulnerable to closure
          </li>
        </ul>
      </div>

      <div class="source-category">
        <h3>Funder Sources (21)</h3>
        <ul class="source-list">
          <li>
            <span class="source-org">SCRA</span> &mdash; SC Launch membership criteria and investment history
            <span class="source-date">(2025)</span><br>
            <a href="https://www.sclaunch.com/" target="_blank">sclaunch.com</a> &mdash; Cited for: $15M fund, $2.9B follow-on, membership criteria, acceptance rate
          </li>
          <li>
            <span class="source-org">SCRA</span> &mdash; Center for Cybersecurity launch announcement
            <span class="source-date">(December 2025)</span><br>
            <a href="https://www.scra.org/news/scra-launches-center-for-cybersecurity/" target="_blank">scra.org</a> &mdash; Cited for: Strategic cybersecurity priority, ThreatCaptain investment
          </li>
          <li>
            <span class="source-org">Town Hall Ventures</span> &mdash; Investment thesis and portfolio
            <span class="source-date">(2025)</span><br>
            <a href="https://www.townhallventures.com/" target="_blank">townhallventures.com</a> &mdash; Cited for: $1M&ndash;$25M range, underserved populations focus, Andy Slavitt co-founder
          </li>
          <li>
            <span class="source-org">CommonSpirit Ventures</span> &mdash; Fund overview and portfolio
            <span class="source-date">(2025)</span><br>
            <a href="https://www.commonspirit.org/what-we-do/innovation/commonspirit-ventures" target="_blank">commonspirit.org</a> &mdash; Cited for: $250M fund, 36 investments, CAH operations in 21 states
          </li>
          <li>
            <span class="source-org">Flare Capital Partners</span> &mdash; Fund overview and portfolio (ClearDATA investment)
            <span class="source-date">(2024&ndash;2025)</span><br>
            <a href="https://www.flarecapital.com/" target="_blank">flarecapital.com</a> &mdash; Cited for: $1B AUM, $1M&ndash;$8M checks, healthcare cybersecurity precedent
          </li>
          <li>
            <span class="source-org">Ballistic Ventures</span> &mdash; Fund overview and thesis
            <span class="source-date">(2024&ndash;2025)</span><br>
            <a href="https://www.ballisticventures.com/" target="_blank">ballisticventures.com</a> &mdash; Cited for: $600M+ fund, cybersecurity-only, Seed/Series A focus
          </li>
          <li>
            <span class="source-org">Ten Eleven Ventures</span> &mdash; Fund overview and portfolio (Anatomy IT investment)
            <span class="source-date">(2024&ndash;2025)</span><br>
            <a href="https://www.teneleven.vc/" target="_blank">teneleven.vc</a> &mdash; Cited for: $1B+ AUM, cybersecurity-focused, healthcare-adjacent portfolio
          </li>
          <li>
            <span class="source-org">Cultivation Capital</span> &mdash; Cybersecurity and Healthcare fund overviews
            <span class="source-date">(2024&ndash;2025)</span><br>
            <a href="https://cultivationcapital.com/" target="_blank">cultivationcapital.com</a> &mdash; Cited for: Dual cyber + healthcare funds, $100K&ndash;$3.5M checks
          </li>
          <li>
            <span class="source-org">MassChallenge</span> &mdash; HealthTech and Cybersecurity program details
            <span class="source-date">(2025&ndash;2026)</span><br>
            <a href="https://masschallenge.org/" target="_blank">masschallenge.org</a> &mdash; Cited for: Zero-equity model, dual-track eligibility, April 2026 deadline
          </li>
          <li>
            <span class="source-org">MACH37</span> &mdash; Cybersecurity accelerator program details and outcomes
            <span class="source-date">(2024&ndash;2025)</span><br>
            <a href="https://www.mach37.com/" target="_blank">mach37.com</a> &mdash; Cited for: 94 graduates, 83% survival, 64% funded, 5% equity
          </li>
          <li>
            <span class="source-org">Health Wildcatters</span> &mdash; Healthcare accelerator program details
            <span class="source-date">(2024&ndash;2025)</span><br>
            <a href="https://www.healthwildcatters.com/" target="_blank">healthwildcatters.com</a> &mdash; Cited for: $30K&ndash;$380K for 8% equity, top-ranked healthcare accelerator
          </li>
          <li>
            <span class="source-org">MUSC Zucker Institute for Innovation Commercialization</span> &mdash; Support programs
            <span class="source-date">(2025)</span><br>
            Cited for: SC-based healthcare innovation support, MUSC network access
          </li>
          <li>
            <span class="source-org">3Phase</span> &mdash; SBIR/STTR readiness program
            <span class="source-date">(2025)</span><br>
            Cited for: SBIR preparation services, grant readiness training
          </li>
          <li>
            <span class="source-org">Y Combinator</span> &mdash; Healthcare and cybersecurity batch data
            <span class="source-date">(2024&ndash;2025)</span><br>
            Cited for: Landscape analysis of accelerator-funded healthcare cybersecurity companies
          </li>
          <li>
            <span class="source-org">Techstars</span> &mdash; Healthcare and cybersecurity program data
            <span class="source-date">(2024&ndash;2025)</span><br>
            Cited for: Landscape analysis of accelerator-funded cybersecurity companies
          </li>
          <li>
            <span class="source-org">SC Venture Capital Authority</span> &mdash; State venture investment programs
            <span class="source-date">(2025)</span><br>
            Cited for: South Carolina state-level venture ecosystem context
          </li>
          <li>
            <span class="source-org">New Enterprise Associates (NEA)</span> &mdash; Healthcare portfolio
            <span class="source-date">(2024&ndash;2025)</span><br>
            Cited for: Large-scale healthcare VC landscape context
          </li>
          <li>
            <span class="source-org">General Catalyst / HATCo</span> &mdash; Healthcare operating company model
            <span class="source-date">(2024&ndash;2025)</span><br>
            Cited for: Alternative healthcare investment models relevant to rural health
          </li>
          <li>
            <span class="source-org">a16z Bio + Health</span> &mdash; Healthcare investment thesis
            <span class="source-date">(2024&ndash;2025)</span><br>
            Cited for: Healthcare VC landscape context and investment thesis analysis
          </li>
          <li>
            <span class="source-org">SYN Ventures</span> &mdash; Cybersecurity fund and thesis
            <span class="source-date">(2024&ndash;2025)</span><br>
            Cited for: Cybersecurity-dedicated VC landscape analysis
          </li>
          <li>
            <span class="source-org">DataTribe</span> &mdash; Cybersecurity startup studio and fund
            <span class="source-date">(2024&ndash;2025)</span><br>
            Cited for: Cybersecurity venture building model comparison
          </li>
        </ul>
      </div>

      <div class="source-category">
        <h3>News Sources (3)</h3>
        <ul class="source-list">
          <li>
            <span class="source-org">Becker's Hospital Review</span> &mdash; ARPA-H funding cuts and healthcare cybersecurity reporting
            <span class="source-date">(2025)</span><br>
            <a href="https://www.beckershospitalreview.com/" target="_blank">beckershospitalreview.com</a> &mdash; Cited for: ARPA-H funding uncertainty, healthcare cybersecurity policy developments
          </li>
          <li>
            <span class="source-org">Modern Healthcare</span> &mdash; Rural health funding and cybersecurity reporting
            <span class="source-date">(2025)</span><br>
            Cited for: CMS RHT Program coverage, rural hospital cybersecurity context
          </li>
          <li>
            <span class="source-org">FedScoop / CyberScoop</span> &mdash; Federal cybersecurity program reporting
            <span class="source-date">(2024&ndash;2025)</span><br>
            Cited for: ARPA-H program status, federal healthcare cybersecurity investment reporting
          </li>
        </ul>
      </div>

      <div class="source-category">
        <h3>Deal Sources (3)</h3>
        <ul class="source-list">
          <li>
            <span class="source-org">SCRA / ThreatCaptain</span> &mdash; Investment announcement
            <span class="source-date">(February 2025)</span><br>
            <a href="https://www.scra.org/" target="_blank">scra.org</a> &mdash; Cited for: $250K equity + $50K grant; SC cybersecurity investment precedent
          </li>
          <li>
            <span class="source-org">Flare Capital / ClearDATA</span> &mdash; Investment data
            <span class="source-date">(2024)</span><br>
            Cited for: Healthcare cybersecurity VC investment precedent
          </li>
          <li>
            <span class="source-org">Ten Eleven / Anatomy IT</span> &mdash; Investment data
            <span class="source-date">(2024)</span><br>
            Cited for: Healthcare-adjacent cybersecurity VC investment precedent
          </li>
        </ul>
      </div>

      <div class="source-category">
        <h3>Technology Sources (1)</h3>
        <ul class="source-list">
          <li>
            <span class="source-org">Microsoft</span> &mdash; Rural Hospital Cybersecurity Landscape Report and Cybersecurity Program
            <span class="source-date">(March 2025)</span><br>
            <a href="https://cdn-dynmedia-1.microsoft.com/is/content/microsoftcorp/microsoft/msc/documents/presentations/CSR/TSI-Rural-Hospital-Cybersecurity-Landscape-Report-2025.pdf" target="_blank">microsoft.com</a> &mdash; Cited for: 700+ rural hospitals enrolled; market context for rural cybersecurity funding need
          </li>
        </ul>
      </div>

    </div>

    <p style="margin-top: 2rem; font-size: 0.85rem; color: var(--text-muted);">
      Sources without direct URLs are institutional publications, fund documentation, or proprietary databases where permanent public links are not available. Full bibliographic detail is maintained in sources.md.
    </p>
  </div>
</section>

<!-- Footer -->
<footer>
  <div class="container">
    <p>CyberShield Rural &mdash; Capital Thesis v2.0 &mdash; 2026-01-29 &mdash; Venture Forge</p>
  </div>
</footer>

<script>
  // Smooth scroll
  document.querySelectorAll('a[href^="#"]').forEach(anchor => {
    anchor.addEventListener('click', function(e) {
      e.preventDefault();
      const target = document.querySelector(this.getAttribute('href'));
      if (target) target.scrollIntoView({ behavior: 'smooth' });
    });
  });

  // Accordion toggle
  document.querySelectorAll('.accordion-header').forEach(header => {
    header.addEventListener('click', function() {
      const item = this.parentElement;
      item.classList.toggle('open');
    });
  });
</script>

</body>
</html>
